1. Chase, T. N., Murphy, D. L.: Serotonin and central nervous system function. In: Annual review of pharmacology, vol 13. H. W. Elliot, R. Okun, and R. George, eds., pp. 181?197. California: Annual Reviews Inc. 1973
2. Costall, B., naylor, R. J.: Stereotyped and circling behavior induced by dopaminergic agonists after lesions of the mid brain raphe nuclei. Eur. J. Pharmacol. 29, 206?222 (1974a)
3. Costall, B., Naylor, R. J.: Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur. J. Pharmacol. 27, 46?58 (1974b)
4. Franz, D. N.: Drugs for Parkinson's disease; centrally acting muscle relaxants. In: The pharmacological basis of therapeutics, L. S. Goodman and A. Gilman, eds., pp. 227?244. New York: Macmillan Publishing Co., Inc. 1975
5. Hamon, M., Bourgoin, S., Enjaber, A., Bockaert, J., Hery, F., Ternaux, J. P., Glowinski, J.: The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 294, 99?108 (1976)